We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Jecure Therapeutics

News List

Roche subsidiary Genentech to acquire Jecure Therapeutics pharmaceutical-technology
November 30, 2018
Swiss firm Roche Group’s affiliate Genentech has agreed to acquire US biotechnology company Jecure Therapeutics to strengthen its position in the treatment of liver diseases.....
Genentech Acquires Jecure Therapeutics americanpharmaceuticalreview
November 29, 2018
Jecure Therapeutics announced a definitive agreement by which it will be acquired by Genentech, a member of the Roche Group. With this acquisition, Genentech will obtain full rights to Jecure’s entire preclinical portfolio of NLRP3 inhibitors......
Roche inks deal to purchase Jecure Therapeutics firstwordpharma
November 28, 2018
Roche's Genentech unit has entered into a definitive agreement to acquire Jecure Therapeutics, obtaining full rights to the latter’s entire preclinical portfolio of NLRP3 inhibitors, Jecure announced Tuesday. Financial terms of the deal were not divulged.